These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 18549846

  • 1. Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry).
    Yan BP, Duffy SJ, Clark DJ, Lefkovits J, Warren R, Gurvitch R, Lew R, Sebastian M, Brennan A, Andrianopoulos N, Reid CM, Ajani AE, Melbourne Interventional Group.
    Am J Cardiol; 2008 Jun 15; 101(12):1716-22. PubMed ID: 18549846
    [Abstract] [Full Text] [Related]

  • 2. Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction.
    Jensen LO, Maeng M, Thayssen P, Kaltoft A, Tilsted HH, Bøttcher M, Lassen JF, Hansen KN, Krusell LR, Rasmussen K, Pedersen KE, Pedersen L, Paaske Johnsen S, Sørensen HT, Thuesen L.
    Circ Cardiovasc Interv; 2008 Dec 15; 1(3):176-84. PubMed ID: 20031676
    [Abstract] [Full Text] [Related]

  • 3. Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry.
    Yan BP, Ajani AE, New G, Duffy SJ, Farouque O, Shaw J, Sebastian M, Lew R, Brennan A, Andrianopoulos N, Reid C, Clark DJ, Melbourne Interventional Group Investigators.
    Int J Cardiol; 2008 Nov 28; 130(3):374-9. PubMed ID: 18706719
    [Abstract] [Full Text] [Related]

  • 4. Comparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study).
    Maresta A, Varani E, Balducelli M, Varbella F, Lettieri C, Uguccioni L, Sangiorgio P, Zoccai GB, DESSERT Investigators.
    Am J Cardiol; 2008 Jun 01; 101(11):1560-6. PubMed ID: 18489933
    [Abstract] [Full Text] [Related]

  • 5. Comparison of drug-eluting versus bare metal stents on later frequency of acute myocardial infarction and death.
    Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Little WC.
    Am J Cardiol; 2007 Feb 01; 99(3):333-8. PubMed ID: 17261393
    [Abstract] [Full Text] [Related]

  • 6. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A, Leon MB, Lansky AJ, Nikolsky E, Aoki J, Moses JW, Schofer J, Morice MC, Schampaert E, Kirtane AJ, Popma JJ, Parise H, Fahy M, Mehran R.
    J Am Coll Cardiol; 2009 Sep 01; 54(10):894-902. PubMed ID: 19712798
    [Abstract] [Full Text] [Related]

  • 7. Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes.
    Tamburino C, Di Salvo ME, Capodanno D, Palmerini T, Sheiban I, Margheri M, Vecchi G, Sangiorgi G, Piovaccari G, Bartorelli A, Briguori C, Ardissino D, Di Pede F, Ramondo A, Inglese L, Petronio AS, Bolognese L, Benassi A, Palmieri C, Filippone V, De Servi S.
    Am J Cardiol; 2009 Jan 15; 103(2):187-93. PubMed ID: 19121434
    [Abstract] [Full Text] [Related]

  • 8. Meta-analysis comparison (nine trials) of outcomes with drug-eluting stents versus bare metal stents in patients with diabetes mellitus.
    Patti G, Nusca A, Di Sciascio G.
    Am J Cardiol; 2008 Nov 15; 102(10):1328-34. PubMed ID: 18993150
    [Abstract] [Full Text] [Related]

  • 9. Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions.
    Jensen LO, Maeng M, Kaltoft A, Thayssen P, Hansen HH, Bottcher M, Lassen JF, Krussel LR, Rasmussen K, Hansen KN, Pedersen L, Johnsen SP, Soerensen HT, Thuesen L.
    J Am Coll Cardiol; 2007 Jul 31; 50(5):463-70. PubMed ID: 17662400
    [Abstract] [Full Text] [Related]

  • 10. Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).
    Patel MR, Pfisterer ME, Betriu A, Widmisky P, Holmes DR, O'Neill WW, Stebbins A, Van de Werf F, Armstrong PW, Granger CB, APEX-AMI Investigators.
    Am J Cardiol; 2009 Jan 15; 103(2):181-6. PubMed ID: 19121433
    [Abstract] [Full Text] [Related]

  • 11. The incidence and clinical predictors of early stent thrombosis in patients with acute coronary syndrome.
    Beinart R, Abu Sham'a R, Segev A, Hod H, Guetta V, Shechter M, Boyko V, Behar S, Matetzky S.
    Am Heart J; 2010 Jan 15; 159(1):118-24. PubMed ID: 20102877
    [Abstract] [Full Text] [Related]

  • 12. Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation.
    Stone GW, Ellis SG, Colombo A, Dawkins KD, Grube E, Cutlip DE, Friedman M, Baim DS, Koglin J.
    Circulation; 2007 Jun 05; 115(22):2842-7. PubMed ID: 17515458
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.
    Bonello L, De Labriolle A, Lemesle G, Roy P, Steinberg DH, Slottow TL, Xue Z, Torguson R, Kaneshige K, Suddath WO, Satler LF, Kent KM, Lindsay J, Pichard AD, Waksman R.
    Am J Cardiol; 2009 Feb 15; 103(4):496-500. PubMed ID: 19195509
    [Abstract] [Full Text] [Related]

  • 15. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F, Tomai F, De Luca G, Boccuzzi G, Presbitero P, Pesarini G, Ferrero V, Ghini AS, Pastori F, De Luca L, Zavalloni D, Soregaroli D, Garbo R, Franchi E, Marino P, Minelli M, Vassanelli C.
    J Cardiovasc Med (Hagerstown); 2009 Feb 15; 10(2):192-9. PubMed ID: 19377384
    [Abstract] [Full Text] [Related]

  • 16. Incidence of coronary stent thrombosis based on academic research consortium definitions.
    Applegate RJ, Sacrinty MT, Little WC, Santos RM, Gandhi SK, Kutcher MA.
    Am J Cardiol; 2008 Sep 15; 102(6):683-8. PubMed ID: 18773988
    [Abstract] [Full Text] [Related]

  • 17. Predictors of death or myocardial infarction during follow-up after coronary stenting with the sirolimus-eluting stent. Results from the prospective multicenter German Cypher Stent Registry.
    Zahn R, Hamm CW, Schneider S, Zeymer U, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Sabin G, Nienaber CA, Senges J, German Cypher Stent Registry.
    Am Heart J; 2006 Dec 15; 152(6):1146-52. PubMed ID: 17161068
    [Abstract] [Full Text] [Related]

  • 18. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
    Ajani AE, Yan BP, Clark DJ, Eccleston D, Walton A, Lew R, Meehan A, Brennan A, Reid C, Duffy SJ, Melbourne Interventional Group (MIG) Investigators.
    Heart Lung Circ; 2007 Aug 15; 16(4):269-73. PubMed ID: 17419097
    [Abstract] [Full Text] [Related]

  • 19. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies.
    Moreno R, Fernández C, Hernández R, Alfonso F, Angiolillo DJ, Sabaté M, Escaned J, Bañuelos C, Fernández-Ortiz A, Macaya C.
    J Am Coll Cardiol; 2005 Mar 15; 45(6):954-9. PubMed ID: 15766835
    [Abstract] [Full Text] [Related]

  • 20. Clinical outcomes following drug-eluting versus bare metal stent implantation for lesion subsets excluded from pivotal clinical trials: findings from the GHOST Study (Guthrie Health System Off-Label StenT Study).
    Harjai KJ, Orshaw P, Shenoy C, Acharji S, Sporn D, Aboufares A, Stapleton D.
    J Interv Cardiol; 2008 Aug 15; 21(4):315-24. PubMed ID: 18754967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.